Search results for: Sian Besley
Filter search results
Funding Challenges in the Malaysian Health Care System
7 January 2020
…for using real world evidence to improve the efficiency of the Malaysian health system. Adrian Towse presented at the Monash Malaysia Health Economics Forum 2019 on three related topics: health…
Sian Hodgson
27 September 2021
Sian is an economist by training, with experience in analysing HTA methodologies, economic evaluations, and pharmaceutical pricing models. Her recent work has also explored healthcare system sustainability and resilience, and…
OHE at IHEA 2023
9 July 2023, 7:00am
…Session Room 1.63- 1.64 Graham Cookson 10/07/2023 10:00-12:00 SAST / 09:00-11:00 BST Proposed Price Regulations for Patented Medicines in Canada Organised Session Clivia Conservatory Sian Besley 10/07/2023 15:00-15:30 SAST /…
OHE at ISPOR Europe 2023
13 November 2023, 12:00am
…15 November 2023 Title Name Time Session type The Race to Improve Health Technology Assessment of Gene Therapies: Which Countries Are Embracing Recommendations? Sian Besley Poster Session Time: 9:00 -11:30…
Rare Disease Day 2024: Why Do We Care About Rare?
29 February 2024
…unaffordable in the short-term. In our most recent work relating to gene therapy, Besley et al. consider whether current HTA methods are fit-for-purpose and highlight key recommendations to better capture…
OHE Awarded Funding for Seven Projects by the EuroQol Research Foundation
18 July 2016
…to explore the interpretation and relevance of the EQ‐5D questionnaire in 4 Asian countries The aim is to explore the appropriateness of the EQ‐5D questionnaire in a number of Asian…
EQ-5D and beyond: OHE’s contributions to EuroQol research and meetings
27 February 2025
…a hearing bolt-on for the EQ-5D-5L. Presenting Author: Sian Hodgson. Co-authors: Nadine Henderson, Rebecca Addo, Mina Bahrampour, Mike Herdman, Kim Rand, Yaling Yang, Brendan Mulhern, Katie Page, Chris Sampson ECR…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
…The UK figures are similar. In contrast, in some of the poorest SSA and South Asian markets, the volume/value relationship between generics’ volume and spend is roughly 1:1. So, when…
OHE’s 50th Celebration: Publications on Tuberculosis Show Constancy and Change
23 August 2012
…black African and South Asian origin varied” with the highest rates being for those who had arrived in the UK most recently. In addition, trips back to the country of…